These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26690378)

  • 41. A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.
    Diamant E; Pass A; Rosen O; Ben David A; Torgeman A; Barnea A; Tal A; Rosner A; Zichel R
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
    Vitale L; Blanset D; Lowy I; O'Neill T; Goldstein J; Little SF; Andrews GP; Dorough G; Taylor RK; Keler T
    Infect Immun; 2006 Oct; 74(10):5840-7. PubMed ID: 16988263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.
    Parker CM; Karchmer AW; Fisher MC; Muhammad KM; Yu PA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S417-S431. PubMed ID: 36251549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel approaches to the treatment of systemic anthrax.
    Artenstein AW; Opal SM
    Clin Infect Dis; 2012 Apr; 54(8):1148-61. PubMed ID: 22438345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptoms associated with anthrax exposure: suspected "aborted" anthrax.
    Cymet TC; Kerkvliet GJ; Tan JH; Gradon JD
    J Am Osteopath Assoc; 2002 Jan; 102(1):41-3. PubMed ID: 11837340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
    Oscherwitz J; Feldman D; Yu F; Cease KB
    Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of anthrax meningitis.
    Sejvar JJ; Tenover FC; Stephens DS
    Lancet Infect Dis; 2005 May; 5(5):287-95. PubMed ID: 15854884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioterrorism. Researchers question obsession with Cipro.
    Enserink M
    Science; 2001 Oct; 294(5543):759-61. PubMed ID: 11679638
    [No Abstract]   [Full Text] [Related]  

  • 50. Bacillus anthracis infections--new possibilities of treatment.
    Żakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Knap J; Cieślik P; Chomiczewski K; Kocik J
    Ann Agric Environ Med; 2015; 22(2):202-7. PubMed ID: 26094508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001.
    JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880-2018: A Systematic Review.
    Hendricks K; Person MK; Bradley JS; Mongkolrattanothai T; Hupert N; Eichacker P; Friedlander AM; Bower WA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S341-S353. PubMed ID: 36251560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
    Quinn CP; Dull PM; Semenova V; Li H; Crotty S; Taylor TH; Steward-Clark E; Stamey KL; Schmidt DS; Stinson KW; Freeman AE; Elie CM; Martin SK; Greene C; Aubert RD; Glidewell J; Perkins BA; Ahmed R; Stephens DS
    J Infect Dis; 2004 Oct; 190(7):1228-36. PubMed ID: 15346332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation Anthrax.
    Lombarte Espinosa E; Villuendas Usón MC; Arribas García J; Jado García I; Huarte Lacunza R; Zárate Chug P; Claraco Vega LM; Jesús Santed Andrés M; Ríos MJ; Cook R; Simard JM; Boyer AE; Rezusta A
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S364-S372. PubMed ID: 36251557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
    Hashimoto M; Boyer JL; Hackett NR; Wilson JM; Crystal RG
    Infect Immun; 2005 Oct; 73(10):6885-91. PubMed ID: 16177368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
    Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
    Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.
    Bouzianas DG
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):665-84. PubMed ID: 17678429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial therapy for anthrax.
    Torres-Tortosa M; Caballero-Granado FJ; Moreno I; Canueto J
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):696; author reply 697. PubMed ID: 12373508
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.
    Karginov VA; Robinson TM; Riemenschneider J; Golding B; Kennedy M; Shiloach J; Alibek K
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):71-4. PubMed ID: 14734189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.